Gene: LMBR1
Official Full Name: limb development membrane protein 1provided by HGNC
Gene Summary: This gene encodes a member of the LMBR1-like membrane protein family. Another member of this protein family has been shown to be a lipocalin transmembrane receptor. A highly conserved, cis-acting regulatory module for the sonic hedgehog gene is located within an intron of this gene. Consequently, disruption of this genic region can alter sonic hedgehog expression and affect limb patterning, but it is not known if this gene functions directly in limb development. Mutations and chromosomal deletions and rearrangements in this genic region are associated with acheiropody and preaxial polydactyly, which likely result from altered sonic hedgehog expression. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20243 | LMBR1 Knockout cell line (HeLa) | Human | LMBR1 | 1:3~1:6 | Negative | Online Inquiry |
KO20244 | LMBR1 Knockout cell line (HCT 116) | Human | LMBR1 | 1:2~1:4 | Negative | Online Inquiry |
KO20245 | LMBR1 Knockout cell line (HEK293) | Human | LMBR1 | 1:3~1:6 | Negative | Online Inquiry |
KO20246 | LMBR1 Knockout cell line (A549) | Human | LMBR1 | 1:3~1:4 | Negative | Online Inquiry |
LMBR1 Gene Knockout Cell Lines are specialized biological tools designed to facilitate the study of the limb and body patterning genes implicated in developmental processes. The LMBR1 gene, identified as a key regulator in limb morphogenesis and associated with various congenital conditions, allows researchers to explore its function in a controlled environment by completely disrupting its normal expression.
These cell lines utilize CRISPR-Cas9 technology, effectively introducing specific gene edits to create targeted knockout models. The knockout mechanism operates through the formation of double-strand breaks at the LMBR1 locus, which are subsequently repaired by non-homologous end joining (NHEJ), leading to the loss of LMBR1 function. This disruption not only aids in confirming the gene's role in biological pathways but also provides insights into the molecular mechanisms underlying limb abnormalities.
The scientific importance of LMBR1 Gene Knockout Cell Lines extends beyond basic research. These models are invaluable for drug discovery and development, as they offer a platform for evaluating therapeutic interventions that target gene-related pathologies. Their application in clinical settings may aid in identifying potential genetic therapies for individuals with limb malformations linked to LMBR1 mutations.
Compared to existing alternatives, these knockout cell lines are characterized by their precise genetic modifications and high efficiency, resulting in reproducible and reliable data. Researchers benefit from a quicker turnaround time when comparing the effects of other genetic manipulations against a thoroughly validated knockout model.
Investing in LMBR1 Gene Knockout Cell Lines represents a strategic decision for researchers, clinicians, and pharmaceutical developers seeking to advance their understanding of genetic contributions to limb development and associated disorders. Our company prides itself on providing cutting-edge genetic tools and has a proven track record of enabling breakthroughs in genetic research. By choosing our products, users align themselves with innovation and expertise in the rapidly evolving field of genetic biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.